Mechanism of Bicalutamide to Breast Cancer Cell Lines MDA-MB-453 and Inhibitory Effects of Its Combination with Everolimus

Mechanism of Bicalutamide to Breast Cancer Cell Lines MDA-MB-453 and Inhibitory Effects of Its Combination with Everolimus

Objective To investigate the effect of bicalutamide on migration and invasion of androgen receptor(AR) positive breast cancer cells and related mechanism, and the effect of mTOR inhibitor everolimus combined with bicalutamide on the proliferation of MDA-MB-453 cells. Methods Western blot was used to...

Full description

Bibliographic Details
Main Authors: ZHANG Yuqin, LU Yunfei, ZHANG Haitian
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2021-03-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
bicalutamide
everolimus
breast cancer
drug combination
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2021.20.0819.htm

Similar Items

Similar Items